| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/13/2002 | US6432690 Cdna codes and isolation mammal proteins and aminno acid sequences |
| 08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
| 08/13/2002 | US6432684 Human nucleotide sequence encode a polypeptide for denaturing polyunsaturated fatty acid |
| 08/13/2002 | US6432680 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 08/13/2002 | US6432677 Nucleic acid molecule codes, interferons and amino acid sequences |
| 08/13/2002 | US6432676 Insulin production and transformation of cells |
| 08/13/2002 | US6432673 Growth factor homolog ZVEGF3 |
| 08/13/2002 | US6432671 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition |
| 08/13/2002 | US6432668 Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE) |
| 08/13/2002 | US6432667 Polynucleotide encoding TIE-2 ligand-4 |
| 08/13/2002 | US6432664 Transformation to produce proteins with amino acid sequences |
| 08/13/2002 | US6432655 Binding and 5-ht receptors and gene expression |
| 08/13/2002 | US6432628 Detection of compounds, enzymes, polypeptides and detection of aspartic acid |
| 08/13/2002 | US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | US6432444 Use of bacterial phage associated lysing enzymes for treating dermatological infections |
| 08/13/2002 | US6432435 Crosslinked thin films or sheets for use as grafting and wound healing agents; nontoxic and nonantigenic |
| 08/13/2002 | US6432409 Hybrid peptides modulate the immune response |
| 08/13/2002 | US6432407 Antigenic protein originating in malassezia |
| 08/13/2002 | US6432406 Method for reducing angiogenesis by administration of a scatter factor inhibitor |
| 08/13/2002 | US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies |
| 08/13/2002 | US6432401 Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist; use in hair graft procedures, for example |
| 08/13/2002 | US6432400 Specific pancreatic lipase inhibitors and their applications |
| 08/13/2002 | US6432398 Methods of treating diseased cells |
| 08/13/2002 | US6432383 Method for administering insulin |
| 08/13/2002 | US6431167 Aerosols; controlling lung delivery |
| 08/13/2002 | US6431166 Aerosols; controlling lung delivery |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/13/2002 | CA2257254C Antibiotic producing microbe |
| 08/13/2002 | CA2202513C Allosteric modulators of the nmda receptor |
| 08/13/2002 | CA2127987C Pharmaceutical bacteriocin compositions |
| 08/13/2002 | CA2088994C Therapeutically active mixture of glutathion and anthocyan compounds |
| 08/13/2002 | CA2080830C Decontaminated biological material |
| 08/13/2002 | CA2045594C Immunogenic compositions against gastrin peptides |
| 08/13/2002 | CA1341382C Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
| 08/09/2002 | CA2371447A1 Modified factor viii cdna and its use for the production of factor viii |
| 08/08/2002 | WO2002061132A1 Antisense modulation of chk2 expression |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | WO2002061082A2 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 08/08/2002 | WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof |
| 08/08/2002 | WO2002061066A1 Method for producing an enzyme from a novel source |
| 08/08/2002 | WO2002061062A2 Human protein kinase n-like polypeptide and uses thereof |
| 08/08/2002 | WO2002061061A2 Inhibition of interleukin-1-beta secretion by card proteins |
| 08/08/2002 | WO2002061060A2 Two splice variants of the human pftaire serine/threonine kinase |
| 08/08/2002 | WO2002061059A2 Carbohydrate metabolism enzymes |
| 08/08/2002 | WO2002061058A2 Regulation of human phospholipase |
| 08/08/2002 | WO2002061057A2 Regulation of human wee1-like serine/threonine protein kinase |
| 08/08/2002 | WO2002061055A2 Methods for regulating the kinase domain of ephb2 |
| 08/08/2002 | WO2002061049A2 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 08/08/2002 | WO2002061044A2 Synthetic peptide and uses for same |
| 08/08/2002 | WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/08/2002 | WO2002061037A2 Administration of nucleic acid sequence to female animal |
| 08/08/2002 | WO2002061036A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 08/08/2002 | WO2002060978A1 Branched polyalkylene glycols |
| 08/08/2002 | WO2002060952A1 Serpin variants and uses thereof |
| 08/08/2002 | WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060947A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060946A2 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 08/08/2002 | WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 08/08/2002 | WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 08/08/2002 | WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | WO2002060933A2 Thioredoxin derived from h. pylori, which is capable of inhibiting nf-kappa b activation |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060930A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060927A1 Protein kinase signalling |
| 08/08/2002 | WO2002060926A2 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060917A2 Method to treat hemophilia |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060486A2 Controlled release microsphere system for administration of drug to the eye |
| 08/08/2002 | WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 08/08/2002 | WO2002060477A1 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same |
| 08/08/2002 | WO2002060475A1 Methods for stabilizing lyophilized blood proteins |
| 08/08/2002 | WO2002060474A2 Mixtures of mushroom enzymes and the use thereof for treating maldigestion |
| 08/08/2002 | WO2002060473A2 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs |
| 08/08/2002 | WO2002060472A1 Remedies for hyponutrition status |
| 08/08/2002 | WO2002060471A2 Ligands for receptor-like protein tyrosine phosphatases |
| 08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | WO2002060468A2 Antiviral activities of primate theta defensins and mammalian cathelicidins |
| 08/08/2002 | WO2002060467A2 Compositions and methods for improving kidney function |
| 08/08/2002 | WO2002060466A2 Gssp3 polynucleotides and polypeptides and uses thereof |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060436A2 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2002060422A2 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | WO2002060420A2 Utilization of a claudin-4 ligand and conjugates thereof in the therapy and diagnosis of tumors |
| 08/08/2002 | WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |